LANTHEUS HOLDINGS INC

Lantheus Hosts Inaugural Investor Day

16 May 2022 15:30:00 By Nasdaq GlobeNewswire

Lantheus Presents Results from a PYLARIFY AI™ Study at the American Urological Association (AUA) Annual Meeting

16 May 2022 07:00:01 By Nasdaq GlobeNewswire

Lantheus Announces First Patient Dosed in Phase 2 Clinical Trial of NM-01 to Monitor PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Patients

13 May 2022 07:00:00 By Nasdaq GlobeNewswire

Lantheus Announces Updates to the NCCN Guidelines for PSMA PET Imaging for Prostate Cancer

11 May 2022 07:00:01 By Nasdaq GlobeNewswire

Lantheus to Present at the UBS Global Healthcare Conference

10 May 2022 07:30:01 By Nasdaq GlobeNewswire

Lantheus Holdings, Inc. Reports First Quarter 2022 Financial Results

29 Apr 2022 06:07:25 By Nasdaq GlobeNewswire

Lantheus Holdings to Host First Quarter 2022 Earnings Conference Call and Webcast on April 29, 2022 at 8:00 a.m. Eastern Time

15 Apr 2022 07:30:00 By Nasdaq GlobeNewswire

Lantheus Appoints Jean-Claude Provost, MD as Interim Chief Medical Officer

04 Apr 2022 07:00:01 By Nasdaq GlobeNewswire

Lantheus Announces Collaboration to Support Prostate Cancer Clinical Development

29 Mar 2022 07:00:01 By Nasdaq GlobeNewswire

Lantheus Holdings to Present at the Barclays Global Healthcare Conference

08 Mar 2022 07:30:00 By Nasdaq GlobeNewswire

Lantheus to Host Inaugural Investor Day

03 Mar 2022 15:30:00 By Nasdaq GlobeNewswire

Lantheus Announces Appointment of Minnie Baylor-Henry as New Board Member

01 Mar 2022 15:05:01 By Nasdaq GlobeNewswire

Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results

24 Feb 2022 06:00:03 By Nasdaq GlobeNewswire

Lantheus Receives U.S. FDA Approval of New Manufacturing Facility

23 Feb 2022 07:00:02 By Nasdaq GlobeNewswire

Lantheus Announces Presentation Featuring PYLARIFY® (Piflufolastat F18) at the 2022 ASCO GU Meeting

10 Feb 2022 16:33:31 By Nasdaq GlobeNewswire

Lantheus Holdings to Host Fourth Quarter and Full Year 2021 Earnings Conference Call and Webcast on February 24, 2022 at 8:00 a.m. Eastern Time

10 Feb 2022 07:30:00 By Nasdaq GlobeNewswire

Lantheus Collaborates with The Prostate Cancer Clinical Trial Consortium (PCCTC) To Advance AI-Enabled Imaging Biomarkers in Prostate Cancer

27 Jan 2022 07:30:00 By Nasdaq GlobeNewswire

Lantheus Appoints Vivian Yao as Chief Human Resources Officer

01 Dec 2021 07:30:00 By Nasdaq GlobeNewswire

Lantheus Announces PYLARIFY AI™ is Now Available

29 Nov 2021 07:30:00 By Nasdaq GlobeNewswire

Lantheus Announces CMS Grants Transitional Pass-Through Payment for PYLARIFY® (piflufolastat F 18) Injection, Effective January 1, 2022

22 Nov 2021 07:30:00 By Nasdaq GlobeNewswire